19
IRUS TotalDownloads
Altmetric
Temporal trends in safety of carotid endarterectomy in asymptomatic patients
File | Description | Size | Format | |
---|---|---|---|---|
Neurology-2015-Munster-WNL.0000000000001781.pdf | Published version | 628.75 kB | Adobe PDF | View/Open |
Title: | Temporal trends in safety of carotid endarterectomy in asymptomatic patients |
Authors: | Munster, AB Franchini, AJ Qureshi, MI Thapar, A Davies, AH |
Item Type: | Journal Article |
Abstract: | Objective: To systematically review temporal changes in perioperative safety of carotid endarterectomy (CEA) in asymptomatic individuals in trial and registry studies. Methods: The MEDLINE and EMBASE databases were searched using the terms “carotid” and “endarterectomy” and “asymptomatic” from 1947 to August 23, 2014. Articles dealing with 50%–99% stenosis in asymptomatic individuals were included and low-volume studies were excluded. The primary endpoint was 30-day stroke or death and the secondary endpoint was 30-day all-cause mortality. Statistical analysis was performed using random-effects meta-regression for registry data and for trial data graphical interpretation alone was used. Results: Six trials (n = 4,431 procedures) and 47 community registries (n = 204,622 procedures) reported data between 1983 and 2013. Registry data showed a significant decrease in postoperative stroke or death incidence over the period 1991–2010, equivalent to a 6% average proportional annual reduction (95% credible interval [CrI] 4%–7%; p < 0.001). Considering postoperative all-cause mortality, registry data showed a significant 5% average proportional annual reduction (95% CrI 3%–9%; p < 0.001). Trial data showed a similar visual trend. Conclusions: CEA is safer than ever before and high-volume registry results closely mirror the results of trials. New benchmarks for CEA are a stroke or death risk of 1.2% and a mortality risk of 0.4%. This information will prove useful for quality improvement programs, for health care funders, and for those re-examining the long-term benefits of asymptomatic revascularization in future trials. |
Issue Date: | 28-Jul-2015 |
Date of Acceptance: | 22-Jan-2015 |
URI: | http://hdl.handle.net/10044/1/43226 |
DOI: | https://dx.doi.org/10.1212/WNL.0000000000001781 |
ISSN: | 0028-3878 |
Publisher: | Medknow Publications |
Start Page: | 365 |
End Page: | 372 |
Journal / Book Title: | Neurology |
Volume: | 85 |
Issue: | 4 |
Copyright Statement: | © 2015 American Academy of Neurology |
Sponsor/Funder: | The Circulation Foundation Rosetrees Trust |
Funder's Grant Number: | N/A A573 |
Keywords: | Science & Technology Life Sciences & Biomedicine Clinical Neurology Neurosciences & Neurology QUALITY IMPROVEMENT PROGRAM VASCULAR-SURGERY GUIDELINES RANDOMIZED CONTROLLED-TRIAL ARTERY STENOSIS MYOCARDIAL-INFARCTION RISK STRATIFICATION CLINICAL-TRIAL OUTCOMES STROKE DEATH Cause of Death Databases, Factual Endarterectomy, Carotid Humans Incidence Patient Safety Postoperative Complications Registries Stroke Neurology & Neurosurgery 1103 Clinical Sciences 1109 Neurosciences 1702 Cognitive Science |
Publication Status: | Published |
Appears in Collections: | Department of Surgery and Cancer |